Unknown

Dataset Information

0

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis.


ABSTRACT: Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor in adults. Despite extensive therapy the prognosis for GBM patients remains poor and the extraordinary therapy resistance has been attributed to intertumoral heterogeneity of glioblastoma. Different prognostic relevant GBM tumor subtypes have been identified based on their molecular profile. This approach, however, neglects the heterogeneity within individual tumors, that is, the intratumoral heterogeneity. Here, we detected the regional immunoreactivity by immunohistochemistry and immunofluorescence using nine different markers on resected GBM specimens (IDH wildtype, WHO grade IV). We found repetitive expression profiles, that could be classified into clusters. These clusters could then be assigned to five pathophysiologically relevant groups that reflect the previously described subclasses of GBM, including mesenchymal, classical, and proneural subtype. Our data indicate the presence of tumor differentiations and tumor subclasses that occur within individual tumors, and might therefore contribute to develop adapted, individual-based therapies.

SUBMITTER: Bergmann N 

PROVIDER: S-EPMC7193089 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis.

Bergmann Natalie N   Delbridge Claire C   Gempt Jens J   Feuchtinger Annette A   Walch Axel A   Schirmer Lucas L   Bunk Wolfram W   Aschenbrenner Thomas T   Liesche-Starnecker Friederike F   Schlegel Jürgen J  

Frontiers in oncology 20200424


Glioblastoma multiforme (GBM) is the most frequent and aggressive primary brain tumor in adults. Despite extensive therapy the prognosis for GBM patients remains poor and the extraordinary therapy resistance has been attributed to intertumoral heterogeneity of glioblastoma. Different prognostic relevant GBM tumor subtypes have been identified based on their molecular profile. This approach, however, neglects the heterogeneity within individual tumors, that is, the intratumoral heterogeneity. Her  ...[more]

Similar Datasets

| S-EPMC9186249 | biostudies-literature
2024-01-04 | GSE247203 | GEO
| S-EPMC6593575 | biostudies-literature
| S-EPMC5906059 | biostudies-literature
| S-EPMC7282886 | biostudies-literature
| S-EPMC2811648 | biostudies-literature
| S-EPMC4992702 | biostudies-literature
| S-EPMC6163053 | biostudies-literature
| S-EPMC4467436 | biostudies-literature
| S-EPMC6539516 | biostudies-literature